This page aggregates IRON's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
IRON run-up, measured
Computed from this stock's own daily closing prices, on the same T-120 basis as the run-up study: the baseline is the close 120 trading sessions before the eve of the decision. These are measurements of what already happened, not predictions.
IRON's past FDA decisions (n=3)
Decision
Outcome
T-120 to eve
T-120 to peak
2026-02-15
CRL
-7.3%
+55.9%
2026-02-13
CRL
+19.9%
+57.5%
2025-01-21
APPROVAL
+27.5%
+47.7%
Median across these 3 decisions: +19.9% from T-120 to the eve, +55.9% to the peak. A median over 3 events describes this stock's past only. It is not a forecast, and the cohort figures on the run-up study are the larger statistical base.